The 3-Biomarker Classifier—A Novel and Simple Molecular Risk Score Predicting Overall Survival in Patients with Colorectal Cancer
A more personalized score might be able to better discriminate low- and high-risk patients and suggest adjuvant treatment compared to classical pathological staging. Our score can serve as a tool to predict outcomes in patients suffering from colorectal carcinoma.
Authors
- Tarik Ghadban (ORCID: https://orcid.org/0000-0002-1894-9893)
- Guido Sauter (ORCID: https://orcid.org/0000-0002-9024-4978)
- Michael Tachezy (ORCID: https://orcid.org/0000-0002-1706-2588)
- Jakob R. Izbicki (ORCID: https://orcid.org/0000-0001-6807-8224)
- Matthias Reeh (ORCID: https://orcid.org/0000-0001-9111-3905)
- Katharina Grupp (ORCID: https://orcid.org/0000-0003-2849-3743)
- Claudia Hube‐Magg (ORCID: https://orcid.org/0000-0001-7542-4340)
- Mohammad Fard-Aghaie (ORCID: https://orcid.org/0000-0002-5798-6590)
- Ronald Simon (ORCID: https://orcid.org/0000-0003-0158-4258)
- Martina Kluth (ORCID: https://orcid.org/0000-0003-4782-4616)
- Nathaniel Melling
Institutions
- Universität Hamburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
Publication Details
- Journal
- Cancers
- Published
- 2024-09-22
- DOI
- https://doi.org/10.3390/cancers16183223
- Citations
- 1
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.42